Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Deep and durable prostate-specific antigen response following comprehensive involved site radiotherapy for prostate cancer oligometastases.
Journal: Urologic oncology
Published: October 27, 2025
Determinants of tumor treating field usage in patients with primary glioblastoma: A single institutional experience.
Journal: Neuro-oncology advances
Published: October 17, 2022
Identifying the optimal cutoff point for MGMT promoter methylation status in glioblastoma.
Journal: CNS oncology
Published: September 06, 2021
Correction to: Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.
Journal: BMC neurology
Published: August 15, 2021
TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients.
Journal: Cancers
Published: December 07, 2020
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.
Journal: BMC neurology
Published: November 27, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 05, 2020
Relationship of Imported Fire Ant (Hymenoptera: Formicidae) Integument Coloration to Cuticular Hydrocarbon and Venom Alkaloid Profiles.
Journal: Environmental entomology
Published: September 25, 2020
Primary CNS lymphoma commonly expresses immune response biomarkers.
Journal: Neuro-oncology advances
Published: March 24, 2020
Tumor Mutational Burden Is Site Specific in Non-Small-Cell Lung Cancer and Is Highest in Lung Adenocarcinoma Brain Metastases.
Journal: JCO precision oncology
Published: December 01, 2019
Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200.
Journal: Journal for immunotherapy of cancer
Published: May 20, 2019
Last Updated: 09/26/2026